Literature DB >> 11469854

Crystal structure of a cocaine-binding antibody.

N A Larsen1, B Zhou, A Heine, P Wirsching, K D Janda, I A Wilson.   

Abstract

Murine monoclonal antibody GNC92H2 was elicited by active immunization with a cocaine immunoconjugate and binds free cocaine with excellent specificity and moderate affinity. Improvement of affinity, as well as humanization of GNC92H2, would be advantageous in immunopharmacotherapy for cocaine addiction, and for emergency cases of drug overdose. Toward this end, the crystal structure of an engineered murine-human chimeric Fab of GNC92H2 complexed with cocaine was determined at 2.3 A resolution. Structural analysis reveals a binding pocket with high shape and charge complementarity to the cocaine framework, which explains the specificity for cocaine, as opposed to the pharmacologically inactive cocaine metabolites. Importantly, the structure provides a foundation for mutagenesis to enhance the binding affinity for cocaine and potent cocaine derivatives, such as cocaethylene, and for additional humanization of the antibody. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469854     DOI: 10.1006/jmbi.2001.4839

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Immunopharmacotherapeutic manifolds and modulation of cocaine overdose.

Authors:  Jennifer B Treweek; Amanda J Roberts; Kim D Janda
Journal:  Pharmacol Biochem Behav       Date:  2011-02-26       Impact factor: 3.533

2.  Noncanonical conformation of CDR L1 in the anti-IL-23 antibody CNTO4088.

Authors:  Alexey Teplyakov; Galina Obmolova; Alison Rogers; Gary L Gilliland
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-02-23

3.  An antidote for acute cocaine toxicity.

Authors:  Jennifer B Treweek; Kim D Janda
Journal:  Mol Pharm       Date:  2012-03-20       Impact factor: 4.939

4.  Structural analysis of free and liganded forms of the Fab fragment of a high-affinity anti-cocaine antibody, h2E2.

Authors:  Kemin Tan; Min Zhou; Angela J Ahrendt; Norma E C Duke; Nassif Tabaja; William J Ball; Terence L Kirley; Andrew B Norman; Andrzej Joachimiak; Marianne Schiffer; Rosemarie Wilton; P Raj Pokkuluri
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-11-05       Impact factor: 1.056

5.  A molecular model for cocaine binding by the immunotherapeutic human/mouse chimeric monoclonal antibody 2E2.

Authors:  Michael Lape; Stefan Paula; William J Ball
Journal:  Eur J Med Chem       Date:  2010-02-06       Impact factor: 6.514

6.  Active immunotherapy for the Treatment of Cocaine Dependence.

Authors:  Berma M Kinsey; Thomas R Kosten; Frank M Orson
Journal:  Drugs Future       Date:  2010-04-01       Impact factor: 0.148

Review 7.  The importance of discerning shape in molecular pharmacology.

Authors:  Sandhya Kortagere; Matthew D Krasowski; Sean Ekins
Journal:  Trends Pharmacol Sci       Date:  2009-01-31       Impact factor: 14.819

8.  Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse-Methamphetamine and 3,4-methylenedioxymethamphetamine.

Authors:  Reha Celikel; Eric C Peterson; S Michael Owens; Kottayil I Varughese
Journal:  Protein Sci       Date:  2009-11       Impact factor: 6.725

9.  Chemoinformatic methods for predicting interference in drug of abuse/toxicology immunoassays.

Authors:  Matthew D Krasowski; Mohamed G Siam; Manisha Iyer; Anthony F Pizon; Spiros Giannoutsos; Sean Ekins
Journal:  Clin Chem       Date:  2009-04-02       Impact factor: 8.327

10.  Molecular similarity methods for predicting cross-reactivity with therapeutic drug monitoring immunoassays.

Authors:  Matthew D Krasowski; Mohamed G Siam; Manisha Iyer; Sean Ekins
Journal:  Ther Drug Monit       Date:  2009-06       Impact factor: 3.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.